tradingkey.logo
tradingkey.logo
Search

Allurion Technologies Inc

ALUR
Add to Watchlist
0.671USD
0.0000.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
5.50MMarket Cap
LossP/E TTM

More Details of Allurion Technologies Inc Company

Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.

Allurion Technologies Inc Info

Ticker SymbolALUR
Company nameAllurion Technologies Inc
IPO dateMar 29, 2021
CEOGaur (Shantanu)
Number of employees134
Security typeOrdinary Share
Fiscal year-endMar 29
Address11 Huron Dr Ste 200
CityNATICK
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code01760
Phone15086474000
Websitehttps://www.allurion.com/en
Ticker SymbolALUR
IPO dateMar 29, 2021
CEOGaur (Shantanu)

Company Executives of Allurion Technologies Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
4.13K
--
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
81.00
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--
Mr. Nicholas Sheridan (Nick) Lewin
Mr. Nicholas Sheridan (Nick) Lewin
Independent Director
Independent Director
--
--
Mr. Mike Cavanaugh
Mr. Mike Cavanaugh
Investor Relations
Investor Relations
--
--
Mr. Keith Johns
Mr. Keith Johns
Independent Director
Independent Director
--
--
Mr. R. Jason Richey
Mr. R. Jason Richey
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
4.13K
--
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
81.00
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Allurion Technologies Inc?

The top five shareholders of Allurion Technologies Inc are: Dr. Shantanu Gaur, M.D.

How many institutions hold shares of Allurion Technologies Inc (ALUR)?

As of 2026Q1, 70 institutions hold shares of Allurion Technologies Inc, with a combined market value of approximately 6.90M, accounting for 46.01% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 132951.00.